Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone versus sufentanil during cardiopulmonary bypass cardiac surgery
ChiCTR2300071938Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jun 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial comparing Oxycodone group with Sufentanil group (2 arms). Primary endpoints: Pulmonary alveolar-arterial oxygen partial pressure difference and C-reactive protein. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
oxycodonesufentanil
Beyond the preview
Go deeper on ChiCTR2300071938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071938.